Donald A. Chambers

2.2k total citations
71 papers, 1.7k citations indexed

About

Donald A. Chambers is a scholar working on Molecular Biology, Periodontics and Cancer Research. According to data from OpenAlex, Donald A. Chambers has authored 71 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 13 papers in Periodontics and 10 papers in Cancer Research. Recurrent topics in Donald A. Chambers's work include Oral microbiology and periodontitis research (12 papers), Protease and Inhibitor Mechanisms (9 papers) and Oral and gingival health research (6 papers). Donald A. Chambers is often cited by papers focused on Oral microbiology and periodontitis research (12 papers), Protease and Inhibitor Mechanisms (9 papers) and Oral and gingival health research (6 papers). Donald A. Chambers collaborates with scholars based in United States, United Kingdom and Austria. Donald A. Chambers's co-authors include Rhonna L. Cohen, Lena L. Neri, John M. Crawford, E W Salzman, Geoffrey Zubay, Robert L. Perlman, Gerald G. Krueger, Lloyd H. Graf, Mario E.A.F. Alves and J Shelby and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Donald A. Chambers

70 papers receiving 1.5k citations

Peers

Donald A. Chambers

PERIO

IMMUN

PHARM

PHYSI

Keiichi Morita Japan

Theodora Danciu United States

Gary L. Peck United States

Dianne C. Duffey United States

Adaling Ogilvie Germany

Yen‐Yun Wang Taiwan

John A. Green United Kingdom

Akira Ohkawara Japan

Jer‐Yuarn Wu Taiwan

Wei‐Ming Wang China

Keiichi Morita Japan

Donald A. Chambers

1.7k ×3.6

190 ×0.6

PERIO

286 ×1.2

IMMUN

60 ×0.3

PHARM

131 ×0.9

PHYSI

Citations per year, relative to Donald A. Chambers Donald A. Chambers (= 1×) peers Keiichi Morita

Countries citing papers authored by Donald A. Chambers

Since Specialization

Citations

This map shows the geographic impact of Donald A. Chambers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donald A. Chambers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donald A. Chambers more than expected).

Fields of papers citing papers by Donald A. Chambers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donald A. Chambers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donald A. Chambers. The network helps show where Donald A. Chambers may publish in the future.

Co-authorship network of co-authors of Donald A. Chambers

This figure shows the co-authorship network connecting the top 25 collaborators of Donald A. Chambers. A scholar is included among the top collaborators of Donald A. Chambers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donald A. Chambers. Donald A. Chambers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

LaJevic, Melissa, et al.. (2010). Thy-1 mRNA destabilization by norepinephrine a 3′ UTR cAMP responsive decay element and involves RNA binding proteins. Brain Behavior and Immunity. 24(7). 1078–1088. 16 indexed citations

LaJevic, Melissa, et al.. (2010). Activation of p38 mitogen-activated protein kinase by norepinephrine in T-lineage cells. Immunology. 132(2). 197–208. 31 indexed citations

Turner‐Warwick, M, Donald A. Chambers, Sue Dopson, & John W Scadding. (2006). Non-clinical training. Other side of the story.. PubMed. 116(5994). suppl 31, 33–suppl 31, 33. 1 indexed citations

Schauenstein, Konrad, I. Rinner, P. Felsner, et al.. (2000). The dialogue between the brain and immune system involves not only the HPA-axis. Zeitschrift für Rheumatologie. 59(S2). II49–II53. 8 indexed citations

Bator, Jenny M., Rhonna L. Cohen, & Donald A. Chambers. (1998). Hydrocortisone Regulates the Dynamics of Plasminogen Activator and Plasminogen Activator Inhibitor Expression in Cultured Murine Keratinocytes. Experimental Cell Research. 242(1). 110–119. 17 indexed citations

Graf, Lloyd H., et al.. (1998). Mechanism of Catecholamine-Mediated Destabilization of Messenger RNA Encoding Thy-1 Protein in T-Lineage Cells. The Journal of Immunology. 161(9). 4825–4833. 42 indexed citations

Chambers, Donald A.. (1995). DNA : the double helix : perspective and prospective at forty years. DigitalGeorgetown (Georgetown University Library). 9 indexed citations

Cook‐Mills, Joan M., Margalit B. Mokyr, Rhonna L. Cohen, Robert L. Perlman, & Donald A. Chambers. (1995). Neurotransmitter suppression of the in vitro generation of a cytotoxic T lymphocyte response against the syngeneic MOPC-315 plasmacytoma. Cancer Immunology Immunotherapy. 40(2). 79–87. 20 indexed citations

Brown, John, Keiko Watanabe, Rhonna L. Cohen, & Donald A. Chambers. (1995). Molecular characterization of plasminogen activators in human gingival crevicular fluid. Archives of Oral Biology. 40(9). 839–845. 30 indexed citations

10.

Cook‐Mills, Joan M., Rhonna L. Cohen, Robert L. Perlman, & Donald A. Chambers. (1995). Inhibition of lymphocyte activation by catecholamines: evidence for a non-classical mechanism of catecholamine action.. PubMed. 85(4). 544–9. 75 indexed citations

11.

Chambers, Donald A., Rhonna L. Cohen, & Robert L. Perlman. (1993). Neuroimmune modulation: Signal transduction and catecholamines. Neurochemistry International. 22(2). 95–110. 46 indexed citations

12.

Cohen, Rhonna L., Keiko Watanabe, Jürg Schmid, John Brown, & Donald A. Chambers. (1992). Plasminogen Activator in Periodontal Health and Disease. Annals of the New York Academy of Sciences. 667(1). 183–185. 3 indexed citations

13.

Imrey, Peter B., et al.. (1991). A cross‐sectional analysis of aspartate aminotransferase in human gingival crevicular fluid. Journal of Periodontal Research. 26(2). 75–84. 36 indexed citations

14.

Schmid, Jürg, Rhonna L. Cohen, & Donald A. Chambers. (1991). Plasminogen activator in human periodontal health and disease. Archives of Oral Biology. 36(3). 245–250. 27 indexed citations

15.

Schmid, Jürg & Donald A. Chambers. (1989). Molecular characterization of plasminogen activator in human supragingival plaque. Archives of Oral Biology. 34(1). 17–21. 8 indexed citations

16.

Cohen, Rhonna L., et al.. (1987). Topographic distribution of Thy-1 positive cells in epithelial tissues of BALB/c mice. Archives of Oral Biology. 32(1). 11–15. 1 indexed citations

17.

Chambers, Donald A., et al.. (1987). Two‐dimensional gel electrophoresis of dog crevicular fluid proteins. Journal Of Clinical Periodontology. 14(6). 320–325. 6 indexed citations

18.

Chambers, Donald A., Rhonna L. Cohen, Julianne J. Sando, & Gerald G. Krueger. (1984). Resistance to 12-0-Tetradecanoyl Phorbol 13-Acetate-Induced Mitogenesis in the Nude Mouse. Pathobiology. 52(1-2). 125–128. 1 indexed citations

19.

Krueger, Gerald G., Donald A. Chambers, & J Shelby. (1980). Epidermal proliferation of nude mouse skin, pig skin, and pig skin grafts. Failure of nude mouse skin to respond to the tumor promoter 12-O-tetradecanoyl phorbol 13-acetate.. The Journal of Experimental Medicine. 152(5). 1329–1339. 21 indexed citations

20.

Chambers, Donald A., et al.. (1970). Research Article 13: Cell-Free Studies on the Regulation of the lac Operon. Cold Spring Harbor Monograph Archive. 1. 375–391. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact